Literature DB >> 16258598

[The bisphosponates: chemical characteristics, skeletal biological effects and extra-skeletal effects].

A Corrado1, F P Cantatore.   

Abstract

Bisphosphonates (BP) are pharmacological compounds whose the most important biological effect is the reduction of bone remodelling, explaining the reason for their use in pathological conditions characterised by an increased bone resorption, such as osteoporosis, Paget's disease, malign hypercalcemia during myeloma and osteolytic bone metastasis. Nevertheless there are several experimental evidence that BP possess different extra-skeletal biological effects, ranging from analgesic properties, anti-inflammatory and pro-inflammatory effects and the capacity of modifying the biological activity of cells other than osteoblasts and osteoclasts, such as the immune system cells and other cells of mesenchymal origin. Several data report the beneficial effects of BP as anti-inflammatory agents in different inflammatory chronic articular diseases, which make BP suitable drugs for treatment of pathologies other than bone disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258598     DOI: 10.4081/reumatismo.2005.142

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  5 in total

1.  Enhancement of subchondral bone quality by alendronate administration for the reduction of cartilage degeneration in the early phase of experimental osteoarthritis.

Authors:  Liu Zhang; Hongyu Hu; Faming Tian; Huiping Song; Yingze Zhang
Journal:  Clin Exp Med       Date:  2011-02-09       Impact factor: 3.984

2.  Multiple systemic diseases complicated by bisphosphonate osteonecrosis: a case report.

Authors:  Fabrizio Carini; Lorena Barbano; Vito Saggese; Dario Monai; Gianluca Porcaro
Journal:  Ann Stomatol (Roma)       Date:  2012-11-14

Review 3.  Clodronate: new directions of use.

Authors:  Bruno Frediani; Ilaria Bertoldi
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26

4.  Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT).

Authors:  Paolo Vescovi; Maddalena Manfredi; Elisabetta Merigo; Marco Meleti; Carlo Fornaini; Jean-Paul Rocca; Samir Nammour
Journal:  Lasers Med Sci       Date:  2009-06-19       Impact factor: 3.161

5.  In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response.

Authors:  Rosangela Montanaro; Alessio D'Addona; Andrea Izzo; Carlo Ruosi; Vincenzo Brancaleone
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.